Home digest
 

Keywords :   


Tag: digest

Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...

2015-11-16 15:58:38| Biotech - Topix.net

Click this link to find out how much you can save.) Last week, Gilead Sciences announced that its Harvoni has been approved by the FDA in new indications. The FDA approved the blockbuster drug for expanded use in patients with genotype 4, 5 and 6 chronic HCV infections and in patients co-infected with HIV.

Tags: label expansion digest biotech

 

Premarket Biotech Digest: Mylan's Perrigo Bid, MannKind Rallies, Merck's Setback

2015-11-13 23:38:00| Biotech - Topix.net

Click this Mylan shares are up more than 11% in pre-market trading today as the company's takeover bid for Perrigo is likely to fail. MYL had launched a hostile bid for PRGO earlier this year.

Tags: bid digest biotech setback

 
 

CSD75: Soybean Digest: Advertising in the 1940s

2015-11-13 21:44:00| Corn & Soybean Digest

The association lost $2,000 in the first year of publishing Soybean Digest, but they vowed to continue support of this valuable information for farmers. Check out these advertisements that we found from November 1940 to October 1941. read more

Tags: advertising digest soybean soybean digest

 

Premarket Biotech Digest: Exelixis' Milestone, Valeant's Investor Call, Sophiris Soars

2015-11-12 05:49:58| Biotech - Topix.net

Click this link to find out how much you can save.) Exelixis achieved a major milestone on Tuesday as the company's Cotellic was approved by the FDA as a treatment for patients with BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma in combination with Zelboraf. Cotellic has already been approved in Switzerland earlier this year.

Tags: call investor digest biotech

 

Premarket Biotech Digest: Anavex's Results, Gilead's HCV Sales, Sanofi's Strategic Roadmap

2015-11-09 20:25:41| Biotech - Topix.net

Click this link to find out how much you can save.) Anavex is down 8% premarket after a large drop on Friday, just before the Nov 7 results from 32 patients in its phase 2a trial part A. I plan to do a thorough study of this tomorrow, but meanwhile, here are a few quick thoughts for those who are undecided about whether to sell or hold. . First, if you want to follow someone's advice, take it in its entirety, don't do it piecemeal.

Tags: results sales strategic digest

 

Sites : [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] next »